Back to Skandinaviska Enskilda Banken AB (publ)

VRTX
Showing 8 of 30 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)'s holdings in VERTEX PHARMACEUTICALS INC

Skandinaviska Enskilda Banken AB (publ) holds 46,000 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $20.5M as of 2026-Q1. The position was decreased (-73.6% shares). VRTX represents 0.5% of Skandinaviska Enskilda Banken AB (publ)'s portfolio.

Current Value

$20.5M

Current Shares

46,000

Total Value Change

-$82M

Total Shares Change

-172,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
46,000
-73.6%
$20.5M0.5%$474.27
0
2025-Q4
Increased
174,466
+13.1%
$79.1M0.3%$453.74
40
2025-Q3
Decreased
154,248
-12.7%
$60.4M0.2%$395.31
0
2025-Q2
Decreased
176,604
-5.3%
$78.6M0.3%$441.30
0
2025-Q1
Increased
186,471
+9.0%
$90.4M0.4%$492.69
39
2024-Q4
Decreased
171,034
-7.7%
$68.3M0.3%$399.35
0
2024-Q3
Decreased
185,285
-15.3%
$86.2M0.4%$462.88
0
2024-Q2
Decreased
218,833
-17.4%
$102.5M0.5%$468.72
0

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used